Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease - PubMed
Review
Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease
Mary E Gaffield et al. Contraception. 2009 Oct.
Abstract
Background: Women diagnosed with gestational trophoblastic disease (GTD) need safe and effective contraception because they are advised to delay a subsequent pregnancy.
Study design: We searched MEDLINE and The Cochrane Library for articles in any language on use of combined oral contraceptives (COC), copper-bearing or levonorgestrel-releasing IUDs among women with benign or malignant GTD, from database inception through November 2008. One review and nine articles were identified and evaluated.
Results: Incidence of postmolar trophoblastic disease was lower among COC users compared with nonusers in six studies, but higher among COC users in three studies. Five studies reported shorter human chorionic gonadotropin (hCG) regression duration among COC users compared with other methods. Development of postmolar trophoblastic disease did not differ significantly among IUD users compared with COC users or nonusers in three studies.
Conclusions: Evidence shows that postmolar trophoblastic disease risk does not increase among women using COCs or an IUD following molar pregnancy evacuation compared with use of other contraceptive methods or no method.
Similar articles
-
Intrauterine devices: an effective alternative to oral hormonal contraception.
[No authors listed] [No authors listed] Prescrire Int. 2009 Jun;18(101):125-30. Prescrire Int. 2009. PMID: 19637436
-
Sivin I. Sivin I. Contracept Fertil Sex (Paris). 1983 Dec;11(12):1287-94. Contracept Fertil Sex (Paris). 1983. PMID: 12312723 French.
-
[The end of IUD marketing in the United States: what does it mean for American women?].
Forrest JD. Forrest JD. Contracept Fertil Sex (Paris). 1987 Mar;15(3):291-300. Contracept Fertil Sex (Paris). 1987. PMID: 12341479 French.
-
Neoplasia with use of intrauterine devices.
Curtis KM, Marchbanks PA, Peterson HB. Curtis KM, et al. Contraception. 2007 Jun;75(6 Suppl):S60-9. doi: 10.1016/j.contraception.2007.01.002. Epub 2007 Feb 20. Contraception. 2007. PMID: 17531619 Review.
-
Fertility after discontinuation of contraception: a comprehensive review of the literature.
Mansour D, Gemzell-Danielsson K, Inki P, Jensen JT. Mansour D, et al. Contraception. 2011 Nov;84(5):465-77. doi: 10.1016/j.contraception.2011.04.002. Epub 2011 Jun 8. Contraception. 2011. PMID: 22018120 Review.
Cited by
-
Al-Talib AA. Al-Talib AA. J Family Community Med. 2016 Sep-Dec;23(3):161-5. doi: 10.4103/2230-8229.189129. J Family Community Med. 2016. PMID: 27625583 Free PMC article.
-
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.
Nguyen AT, Curtis KM, Tepper NK, Kortsmit K, Brittain AW, Snyder EM, Cohen MA, Zapata LB, Whiteman MK; Contributors. Nguyen AT, et al. MMWR Recomm Rep. 2024 Aug 8;73(4):1-126. doi: 10.15585/mmwr.rr7304a1. MMWR Recomm Rep. 2024. PMID: 39106314 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources